Clinical Trials Directory

Trials / Completed

CompletedNCT02809352

Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer

Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program Entitled START-HPV (STudy of Primary Screening in the ARdennes Department by Testing for HPV Infection)

Status
Completed
Phase
Study type
Observational
Enrollment
348 (actual)
Sponsor
CHU de Reims · Academic / Other
Sex
Female
Age
31 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Cervical cancer is due to a persistent infection with a group of viruses known as high-risk Human Papillomaviruses (hrHPV). Viral DNA can be easily detected in a cervical sample by a procedure called 'HPV testing', which can be used as a relevant screening test. A pilot screening program called START-HPV has been set up in the Ardennes, a French administrative area localized in the North of France, with HPV testing as a primary screening test.This observational study aimed to evaluate hrHPV genotypes repartition in the population who participate in the START-HPV screening program. This study will allow a better knowledge of hrHPV infection epidemiology in a screened population.

Conditions

Interventions

TypeNameDescription
BIOLOGICALHuman papillomavirus genotyping

Timeline

Start date
2012-07-01
Primary completion
2014-12-01
First posted
2016-06-22
Last updated
2016-06-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02809352. Inclusion in this directory is not an endorsement.